Assessment of major gaps

Dec 19, 2019

Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.

Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.

Recent News

Subscribe to our Neuroendocrine Cancer Newsletter

Subscribe to our Neuroendocrine Cancer Newsletter

Join our mailing list and receive newsletters, general Neuroendocrine Cancer updates, details of our patient education events and volunteering opportunities.   Subscribe here ➡️  - https://www.tfaforms.com/4605623  

read more
5-HIAA 24 hour Urine Collection Test

5-HIAA 24 hour Urine Collection Test

5-HIAA 24 hour Urine Collection Test Urinary 5-HIAA (5-hydroxyindoleacetic acid) 5-HIAA is a breakdown product of a hormone called serotonin which is excreted from the body in urine. It is an indirect way to measure how much serotonin is in the body. Serotonin can be...

read more
When is a rash not a rash?

When is a rash not a rash?

Name: Sophie Age: 52 Neuroendocrine Cancer Site: Glucagonoma - pancreas (primary), paraaortic retroperitoneal lymph nodes (secondary). Sophie's Story: When is a rash not a rash? My NET story probably begins some time before 2014, but that is the year I first started...

read more